OM
Outset Medical, Inc.
Next earnings Aug 4, 2026 · consensus $-0.74 EPS, $30.7M rev
Last earnings -8.8% on 2026-06-17
$4.58
▼ -0.22%$4.58▼ -73.63%
over 1Y
L $3.16EODHDH $20.90
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.2%
1W-6.1%
1M+4.3%
3M+28.7%
YTD+23.8%
1Y-73.6%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy
Revenue grew 5.1% YoY; but unprofitable (net margin -68.3%).
Revenue (FY2025) $119M · FY2025
Outset Medical, Inc. shows $119M in FY2025 revenue (+5.1% YoY), a -68.3% net margin, and -64.3% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $103M | $115M | $130M | $114M | $119M |
| Gross profit | $7.61M | $17.8M | $29.0M | $38.6M | $46.8M |
| Operating income | -$131M | -$161M | -$170M | -$113M | -$66.7M |
| Net income | -$132M | -$163M | -$173M | -$128M | -$81.7M |
| Diluted EPS | -$2.89 | -$3.38 | -$52.28 | -$36.96 | -$5.37 |
| Net margin | -128.6% | -141.2% | -132.5% | -112.6% | -68.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$150M
EV / EBITDA—
EV / Sales1.3
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-97.4%
FCF yield-56.2%
Quality & risk
ROIC (est.)-23.1%
Free cash flow-$47.1M
Total debt$101M
Net cash-$66.0M
Altman Z-Score-5.25 distress
Piotroski F-Score7/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY-66.0%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-142026-06-17open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-042026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗8-KPeriod ending 2026-06-042026-06-05open ↗144Filing2026-06-03open ↗8-KPeriod ending 2026-05-262026-05-29open ↗SDFiling2026-05-29open ↗
Frequently asked
- Is Outset Medical, Inc. (OM) a buy?
- OM currently carries a Sell rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 5.1% YoY; but unprofitable (net margin -68.3%).
- What is Outset Medical, Inc.'s quality score?
- OM scores 59.98039215686275/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001484612, latest 10-Q filed 2026-05-07) · EODHD · as of 6/20/2026, 7:18:38 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.